LatinoWire

December 13, 2024 02:17 PM Eastern Time

BrightPath Bio en Cellistic kondigen samenwerking aan voor procesontwikkeling en productie voor klinische Fase 1-studie van iPSC-afgeleide BCMA CAR-iNKT-cellen

Opens in new window

Download

Full Size JPEG, 1476x542, 211.5 KB
Small JPEG, 480x176, 39.3 KB
Preview JPEG, 144x53, 6.5 KB
Thumbnail JPEG, 120x44, 4.7 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/latinowire/20241213578906/nl/5761637/

Share

Email

All News | News with Multimedia > Press Release: BrightPath Bio en Cellistic kondigen samenwerki...

Get Business Wire News on Your Website

Terms of Use | © 2024 Business Wire